Temasek leads $65m Series D round in US-based SQZ Biotechnologies

Temasek leads $65m Series D round in US-based SQZ Biotechnologies

Photo by Louis Reed on Unsplash

19 May, 2020

SQZ Biotechnologies Company Temasek

Printed by Unregistered user on Sun, 07 Dec 2025 23:12:25 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Singapore's Temasek joins Facebook-backed digital currency project Libra

SZ-listed Chinese medical device maker Kinetic to raise $155m from Temasek, Hillhouse

Read more from World

Netflix to buy Warner Bros Discovery’s studios, streaming unit for $72b

SoftBank in talks to buy digital infra firm DigitalBridge: report